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Abstract
Background:  Uterine luminal epithelial cell response to different hormonal strategies was
examined to determine commonality when an endometrium attains a receptive, stimulated,
morphological profile that may lead to successful implantation.
Methods: Endometrial biopsies from 3 cohorts of patients were compared. The tissue samples
taken from these patients were categorized into 8 different groups according to their baseline and
the hormone regime used.
Results: Pre-treatment natural cycle tissue was variable in appearance. Downregulation with a
GnRH analogue tissue appeared menopausal in character. HRT after downregulation resulted in
tissue uniformity. HRT in menopause resulted in a 'lush' epithelial surface. HST in the natural cycle
improved the morphology with significant difference in secretion between the two regimes
examined.
Conclusions: Down regulation plus HRT standardized surface appearance but tissue response is
significantly different from the natural cycle, natural cycle plus HRT or menopause plus HRT. HRT
in menopause reinstates tissue to a state similar to a natural cycle but significantly different from a
natural cycle plus HST. HST with a natural cycle is similar to tissue from the natural cycle but
significant differences reflect the influence of the particular hormones present (at any point) within
the cycle.
Background
Successful reproduction in any species relies on a large
number of interactions occurring at molecular, biochemi-
cal and morphological levels in the uterus. Changes in the
uterine epithelium in preparation for implantation are
characterised by a proliferation of cells, their differentia-
tion, and alterations to the topography and composition
of the apical plasma membrane in particular. Cells reach
their maximum growth and sensitivity to the blastocyst at
the time of implantation. This period of maximum sensi-
tivity is referred to as the receptive phase and has a limited
duration or window of time – the 'nidation window'.
Uteri outside this phase of receptivity not only resist
attachment by the blastocyst [1,2] but in many species are
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actively embryotoxic [3]. Thus, the uterus can be thought
of as a primarily hostile environment where successful
implantation and pregnancy are reliant on the precise co-
ordination of events that change the receptivity of the
uterus [4-6].
In 2000, assisted conception treatments accounted for
almost 2% of all births in Australia and New Zealand, and
although the number of births is steadily increasing, the
pregnancy rates using IVF and other assisted reproductive
technologies still remain unsatisfactorily low [7]. One fac-
tor that may impact on the successful outcome of these
technologies is that a majority of the women seeking
assisted conception treatment were aged 30 to 39 years,
with 16.6% being aged 40 years or more [8].
With advancing age and/or a declining hormonal profile,
concomitant with a decline in oocyte quality [9,10], the
endometrium undergoes gradual involution from prolif-
erative to inactive, eventually becoming atrophic (senes-
cent) [11,12]. Perhaps the term 'aging' should be placed in
context: once steroidal output from the ovary is reduced,
there is a corresponding decrease in uterine morphologi-
cal characteristics until the uterine epithelium becomes
atrophic. However, these changes can be reversed and the
morphological characteristics of an intact and functional
epithelium can be reinstated with exogenous hormone
supplementation therapy (HST) [13]. Thus 'aging' is a
term that can be used to describe any uterus that is in a
hormonally deprived condition.
In IVF programs for women with or without functioning
ovaries, the endometrium is prepared artificially using
exogenous hormones in a manner that seeks to imitate the
natural cycle in preparation for embryo transfer (ET). If a
pregnancy develops, exogenous E2 and P4 supplementa-
tion are continued until placental production of P4 is well
established [14]. The administration of P4 before implan-
tation and increasing the P4 dose longer into pregnancy,
has provided a method for correcting hormonal imbal-
ance and enabling a successful pregnancy to be sustained
[15,16,11,17].
Observations on the normal morphological changes of
the uterine epithelium using light and electron micros-
copy have demonstrated that astute hormonal mimicking
of the natural cycle is not necessary for endometrial prep-
aration for implantation. Sequential 'same dose' E2 and P4
regimes (rather than incremental dose regimes) can be
implemented without dose variation throughout the cycle
[18-23]. The follicular phase of the natural cycle can be
manipulated to shorten or extend the length of the cycle
beyond its physiological limits (primarily for the synchro-
nization of donor oocyte cycles with endometrial recep-
tivity in the recipient). Proliferative endometrium under
these conditions has been shown to tolerate follicular
phase durations from as short as 5 to as long as 100 days
prior to the administration of P4 [24,9,21,25,18,26,27].
However, other studies have suggested that the receptivity
of the endometrium, as assessed by pregnancy rate, is best
preserved when the follicular phase is kept between 12
and 19 days [22,23]. Short follicular phases (<11 days)
have been shown to have an adverse effect on clinical out-
come by presenting with early pregnancy loss [28,20,29].
Administration of exogenous E2 and P4 has also been
found to have a threshold effect. Once a minimum thresh-
old level of these hormones is attained, no further mor-
phological endometrial responsiveness is observed
[18,29-31]. However, supraphysiological doses of P4 have
been found to enhance luteal phase endometrial mor-
phology [24,17], while withholding E2 during the luteal
phase has been found to have no adverse affect on
endometrial development, maturation or receptivity
[30,25,32,13].
Regardless of the effects of exogenous hormones, from
any of the several strategies either as adjunctive, replace-
ment or supplemental, the morphological integrity of the
endometrium remains the same [33]. There is however,
consistent evidence of out-of-phase endometria when
HST is used. The appearance and maturity of uterodomes
(pinopods) in addition to the temporal appearance or dis-
appearance of a series of other morphological and histo-
logical characteristics [34,60] suggests that the priming of
the 'window of receptivity' could be advanced or retarded
[35,36].
Uterodomes (apical cellular protrusions) which have
been found to occur at or just prior to the time of implan-
tation have become useful biomarkers in clinical medi-
cine for determining the hormonal condition, and
therefore, state of receptivity of the uterus
[4,17,37,38,35,36,39,40,42,42,43,60]. In a 28 day natural
cycle, uterodomes have been found to appear on D20-21,
in controlled ovarian hyperstimulation cycles they appear
on D19-20 and in hormone controlled cycles on D21-22
[44,39]. These variable 'windows of receptivity' are
another factor that could significantly affect the outcome
of assisted reproduction techniques.
Although the cyclical changes that occur as a response to
E2 and P4 exposure can be monitored on a daily basis by
hormonal blood serum levels and ultrasound observa-
tions, it is the uterine biopsy that allows fine morpholog-
ical assessment of the uterine epithelial ultrastructure.
Scanning electron microscopy (SEM), used to sequentially
date the endometrium, has confirmed the surface cellular
changes observed with transmission electron microscopy
(TEM) and further elucidated important details aboutReproductive Biology and Endocrinology 2004, 2 http://www.rbej.com/content/2/1/21
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topographical features such as the cilia, microvilli, cell
number, ratio, size and shape [37,41,45-48].
Visualization of the uterine epithelium, utilizing uterine
biopsy and SEM, allows accurate endometrial dating,
interpretation of morphological characteristics and the
hormonal status of the epithelium to be assessed. Repeat
endometrial biopsy further allows fine tuning of the exog-
enous hormone administration regime to optimize uter-
ine receptivity, and hopefully, to maximize implantation
[17].
The patient samples used in this comparative study are
representative of several different IVF, HRT or HST treat-
ment regimes and endometrial outcomes. There have
been successful pregnancies for some. Data from meno-
pausal patients represents a unique model for studying
the interaction of exogenously administered E2 and P4 and
endometrial morphology, without the confounding influ-
ence of endogenous ovarian steroid production. This data
provides an indication of the responsiveness that might
be expected from an under-stimulated endometrium in
the presence of exogenous ovarian hormones.
The present study analyses the epithelial response to sev-
eral hormonal strategies used in IVF settings and provides
an insight into the response of the uterine epithelium to
those strategies using repeat uterine biopsy, SEM and a
series of accepted morphological markers to characterize
tissue responsiveness.
Methods
Patient selection and treatment regimes
The present study analyses the morphological appearance
of endometrial biopsies obtained from 4 groups of
patients on an outpatient basis using the Gynoscan (Orga-
non, Aust. Pty.), Novak curette and sedation. The biopsy
was taken from the fundus, 2 cm down on the anterio-
fundal wall of the uterus. All patients gave informed con-
sent and research was conducted according to NH&MRC
National Statement on Ethical Conduct in Research
Involving Humans http://www.health.gov.au/nhmrc/
publications/humans/contents.htm.
Figure 1 represents the treatment regimes and indicates
the timelines for biopsy.
The groups were organized as follows:
Natural Cycle Control Patients
This group was further subdivided to determine whether
time between stimulation regimes had an effect on the
responsiveness of uterine tissue.
Group 1 – Natural Cycle Control (no HST for 3 months)
Ten patients between 28–41 years (mean age 34.3 years),
attending an IVF clinic, who were not anovulatory, had
taken no hormone supplementation, and had not under-
gone stimulation in the previous 3 months were included
in this group. These women volunteered to have a uterine
assessment for 1 cycle prior to their treatment cycle for ET
and underwent one uterine biopsy 4 days after LH surge,
as determined by blood serum hormone sample – D18
(D4P) on the assumption that, on a 28 day natural cycle,
the secretory epithelium would be equivalent to that of 4
days of progesterone effects. Patients from this group went
on to participate in the downregulation study (Groups 3
and 4).
Group 2 – Natural Cycle Control (previous HST)
Twenty-three infertile women between the ages 28 – 43.5
(mean age 34.7 years), having cryopreserved embryos
from previous in vitro fertilization attempts, were
recruited to take part in the study. Four women did not
complete the study for individual reasons leaving 19
women in the final analyses. Each participant was diag-
nosed with one or more of the following: 12 with tubal
factor, 4 with endometriosis, 7 with male factor, 2 with
PCOD, 1 with bi-cornate uterus and 1 idiopathic
infertility.
These women volunteered to have a uterine assessment
for 1 cycle prior to their treatment. Biopsies were taken on
D19 (D5P). Patients from this group went on to partici-
pate in the short and long follicular cycle study (Groups 7
and 8)
Groups 3 – Down-Regulation, and Group 4 – Down-regulation plus 
HRT
The 10 patients, 28–41 years (mean age 34.3 years),
attending an IVF clinic who had more than 4 frozen
embryos from previous ET attempts, were commenced on
Synarel (nafarelin acetate) (Searle, Monsanto, Sydney), a
GnRH agonist for pituitary suppression, prior to exoge-
nous E2 and P4 replacement. Synarel was delivered in
measured micronised doses of 200 mcg per nasal puff.
Each patient underwent 2 consecutive treatment cycles.
Treatment Regime
• Synarel given as 2 intranasal puffs twice daily was com-
menced on Day 1 of cycle 1 and continued daily for 2
cycles. Two patients in this group underwent a uterine
biopsy on D19 of this downregulation cycle (Group 3).
• Estigyn (ethinylestradiol, Glaxo, Wellcome, Australia)
50 mcg/day was commenced on Day 1 of the second cycle
and continued throughout the cycle.Reproductive Biology and Endocrinology 2004, 2 http://www.rbej.com/content/2/1/21
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Representation of the treatment timelines, regimes used and biopsy days Figure 1
Representation of the treatment timelines, regimes used and biopsy days.
.
Key to treatments administered 
Nafarelin acetate 200 mcg per nasal puff (2 puffs per day)
Ethinylestradiol 50mcg/day
Oestradiol valerate 2mg daily
Progesterone (USP) 300 mg/day (Vaginal pressary)
Medroxyprogesterone acetate 10mg daily
Biopsy
Natural Cycle
Treatment Cycle 1 Treatment Cycle 2
D1 D1
D8 D15
1st Biopsy 2nd Biopsy 3rd Biopsy
D19 (D5P) D10 (D3P) or D12 (D5P) D19 (D5P) or D22 (D8P)
Downregulated Cycle
Treatment Cycle 1 Treatment Cycle 2
D1
D1
D15
1st Biopsy 2nd Biopsy 3rd Biopsy
D18 (D4P) D19 (2 patients only) D19 (D5P) 
Menopause
Treatment Cycle 1 Treatment cycle 2
D1 D1
D14 D14
1st Biopsy 2nd Biopsy
Prior to commencement of treatment D20 (D7P)Reproductive Biology and Endocrinology 2004, 2 http://www.rbej.com/content/2/1/21
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• Sequential progesterone (USP) 300 mg/day, as vaginal
pessaries, was commenced on Day 15 of the second cycle.
• Uterine biopsy was taken 4 days later – D19 (D5P)
(Group 4).
Group 5 – Menopause Control, and Group 6 – Menopause plus HRT
This group was originally composed of 27 patients (age
range 47–59 years; mean age 55 years) with samples from
18 patients being used in the final analyses. Nine patients
were eliminated from the study due to stenosis of the cer-
vical os making uterine biopsy unfeasible. All patients had
amenorrhoea for at least six months prior to biopsy, a FSH
level in the postmenopausal range and had taken no HRT
6 months prior to the study. Each patient had two biop-
sies. The first biopsy was taken prior to the commence-
ment of HRT and was used as a baseline against which to
compare subsequent findings. Patients were within a sec-
ond sequential HRT treatment cycle when the subsequent
biopsy was taken at D20 = 6 days P. However, 2 biopsies
were taken on D19 (5 days P) and one on D23 (9 days P)
of the cycles.
Treatment Regime
• Progynova (oestradiol valerate, Schering, FRG) 2 mg
daily
• Sequential Provera (Medroxyprogesterone acetate, Phar-
macia and Upjohn, Sydney) 10 mg daily starting D 14
after E2 commencement, taken for 12 days.
• Regime was repeated for a 2nd cycle.
• 15 uterine biopsy were taken D20 of the 2nd cycle = D6P;
2 biopsies were taken D19 of the 2nd cycle (D5P) and 1 on
D23 (D9P) of the 2nd cycle.
Groups 7 – Natural cycle plus HST: short follicular phase Group 8 – 
Natural cycle plus HST: long follicular phase
The 19 infertile women remaining in the Natural Cycle
Control (previous HST) cohort went on to undergo a
short follicular phase cycle followed sequentially by a
long follicular phase cycle. Serum FSH, LH, oestradiol and
progesterone were measured on the first day of each P
treatment ie: D8 or D15. Seven patients within this cohort
became pregnant in the following consecutive ET cycle
using the long follicle phase protocol [13].
Group 7 – Treatment Regime 1 – Short Follicular Phase
• Estigyn (ethinylestradiol) 50 mcg/day was commenced
on Day 1 of the first treatment cycle and continued
throughout the cycle.
• Sequential progesterone (USP) 300 mg/day, as vaginal
pessaries, was commenced on D8 of the first treatment
cycle.
• Uterine biopsy was taken 3 or 5 days later; D10 (D3P),
or D12 (D5P).
Group 8 – Treatment Regime 2 – Long Follicular Phase
• Estigyn (ethinylestradiol) 50 mcg/day was commenced
on Day 1 of the second treatment cycle and continued
throughout the cycle.
• Sequential progesterone (USP) 300 mg/day, as vaginal
pessaries, was commenced on D15 of the second treat-
ment cycle.
• Uterine biopsy was taken 5 or 8 days later; D19 (D5P)
or D22 (D8P).
Tissue preparation for Scanning Electron Microscopy (SEM)
Uterine biopsies were immediately rinsed in 0.1 M PO4
buffer, pH 7.4, (PB), fixed in 2.5% Glutaraldehyde (EM
Grade; TAAB, UK) in PB for 1.5 hours and rinsed with PB
prior to further processing.
After initial fixation, the tissue was cut into 3 mm pieces
and post fixed in aqueous 2% Osmium Tetroxide (OsO4)
(Johnson Matthey, Materials Technology U.K.) for one
hour. Tissue was then rinsed in distilled water, dehydrated
through graded ethanols 50–100% with a final wash in
absolute alcohol for critical point drying in liquid CO2
(Baltec). Dried tissue was mounted onto aluminium
stubs, edged with conductive silver dag, sputter coated to
20 nm with platinum/gold in a planar magnetron sputter
coater and viewed using a Philips Scanning Electron
Microscope (SEM) 505 operating at 20 keV.
Data collection
Image collection was by digital capture at the SEM level of
observation, using a standard series of magnifications:
X525, X1050, X2100, X4200 and X8400.
Morphological analysis of tissue
Table 1 shows the 20 SEM epithelial characteristics and
their descriptions used in the morphological assessment
of the uterine biopsies [46,49,47,50,48,17]. These obser-
vational markers were scored as follows:
0 = Nil, absent
1 = some, few, barely present, low, small
2 = moderate, averageReproductive Biology and Endocrinology 2004, 2 http://www.rbej.com/content/2/1/21
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3 = abundant, large, wide, high
Uterodome assessment
Abundance
Uterodomes were graded according to the criteria set
down by Nikas and Pyschoyos, [36] such that their abun-
dance (number) was scored in three grades: abundant,
moderate  or  few, depending on the percentage of the
endometrial surface occupied by uterodomes (>50%, 20–
50%, and 20%, respectively).
Shape
Uterodome shape, denoting the stage of cell maturity, was
graded such that three developmental stages were scored:
developing, fully developed and regressing [39].
Statistics
Data analyses were performed using SPSS v.10 (SPSS Inc,
Chicago, Illinois, US) statistical programme. The non-par-
ametric Wilcoxon Mann-Whitney Test was used to com-
pare groups. The Wilcoxon Mann-Whitney Test is used to
test the null hypothesis that two populations have identi-
cal distribution functions and does not require the
assumption that the differences between the two samples
are normally distributed. In this study, where the normal-
ity assumption is questionable, the Wilcoxon Mann-Whit-
ney Test is used in place of the two sample t-test. A
confidence level of P = or < 0.05 was used to determine
significant difference between groups.
Results
Natural Cycle Control – Groups 1 and 2
Due to the innate intra- and inter-patient variability of the
samples, the morphological analysis from the 2 patient
cohorts have been combined into a single natural cycle
control group referred to as Group 1. The term 'normal' is
used lightly in this study as tissue was derived from
patients attending a fertility clinic.
Morphological analysis
Group 1 – Combined Natural Cycle Control
In general there was a moderate to abundant amount of
epithelium, however, the response within and between
patients, with regard to the morphological characteristics,
was variable.
Several patients were observed to have a well stimulated
secretory epithelium consistent with Day 4P or 5P, dis-
playing developing or fully developed uterodomes
(Figure 2a). In contrast, a number of samples showed epi-
thelium that was suboptimal and representative of early
proliferative epithelium (Figure 2b). Microvillous cells
were flat and sparsely covered with low, blebbed micro-
villi. Ciliated cells were infrequent and the cilia low and
numerically reduced. In some cases these out of phase epi-
thelia displayed large pleiomorphic cells, raised cell bor-
ders and exhibited poor ciliation.
In addition to inter-patient variability, several samples
demonstrated an intra-patient variable response with
large areas of tissue heterogeneity. Tissue appearance var-
ied from areas of small polygonally shaped microvillous
cells with well developed microvilli, cell protrusion and
secretory droplets, to areas of flattened or protruding epi-
thelium with obvious cell borders between large pleio-
morphic cells (Figure 2c).
Glands also varied in number and appearance. Samples
observed displayed glands that were moderately abun-
dant with large, gaping openings; glands that were raised
on circular hillocks with slit like openings (Figure 3a); or
glands that were flat with circular openings (Figure 3b).
The results indicated that patients not displaying utero-
domes on Day 4P or 5P of presumed P4 exposure also had
an epithelium that was found to be suboptimal or
retarded in hormonal response.
Table 1: Twenty epithelial characteristics and their descriptions used to evaluate uterine biopsies using SEM
Epithelial Characteristics – Graded 0–3
1. Epithelial abundance – the amount of epithelium found within the sample 11. Cell separation – at times cells are observed to be separate rather than tightly 
clustered together
2. Tissue heterogeneity – the variability of tissue surfaces within the sample 12. Denuded apices – cell surfaces are devoid of surface modifications such as 
microvilli, cilia (excluding uterdomes)
3. Cell heterogeneitiy – the variability of the appearance of the cell types within each 
field
13. Flattened cells – degree to which cells display a flattened topography
4. Gland abundance – the relative number of glands observed within each field 14. Deflated cells – whether cell apices appear to have collapsed or withered
5. Gland opening – the types of gland opening, whether wide, raised, narrow 15. Apical protrusion – the degree to which the cell surface protrudes into the lumen 
of the uterus
6. Cilia groups – the relative number of ciliated cells clustered together 16. Uterodomes – shape (see Uterodome Assessment)
7. Single cilium – presence of these indicate a senescent or atrophying epithelium 17. Uterodomes – abundance (see Uterodome Assessment)
8. Microvilli height – the relative length of microvilli, from short and blebbed to long 18. Cell borders -may be obvious or deeply recessed between cells
9. Microvilli density – relative number of microvilli per cell, from few to many 19. Secretion – the presence of secretory product within the field or on cell surfaces
10. Apical membrane defects – include observation of porosity and degeneration 20. Plicae – are microvillous folds or ridges on the cell surfacesReproductive Biology and Endocrinology 2004, 2 http://www.rbej.com/content/2/1/21
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Group 3 – Down-regulation only
Unfortunately only 2 patients within the cohort had a
biopsy taken within the first downregulation treatment
cycle where only a GnRH agonist was administered.
Observations of morphological characteristics indicated
an epithelium that was unstimulated, flat and displayed a
topography similar to that observed in post menopausal
uteri of Group 5. Epithelial surface was flattened with cells
displaying raised cell borders. There was evidence of cell
separation, cell loss and apical membrane defects, such as
cell porosity, (Figure 4a). Glands with large openings were
also observed.
SEM of uterine epithelium at D4P from different women dur- ing a natural cycle Figure 2
SEM of uterine epithelium at D4P from different women dur-
ing a natural cycle. (A) Several patients showed a well stimu-
lated, secretory epithelium consistent with Day 4P or 5P, 
displaying developing or fully developed uterodomes. Scale 
bar = 5 µm. (B) In contrast some patients showed an epithe-
lium that was suboptimal and representative of early prolifer-
ative epithelium. Microvillous cells were flat and sparsely 
covered with low, blebbed microvilli. Ciliated cells are infre-
quent and the cilia low and numerically reduced. Scale bar = 
10 µm. (C) Tissue appearance varied from areas of small 
polygonally shaped microvillous cells with well developed 
microvilli, cell protrusion and secretory droplets, to areas of 
flattened or protruding epithelium with obvious cell borders 
between large pleiomorphic cells. Scale bar = 10 µm.
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SEM at D4P showing gland variability between samples from  women during a natural cycle Figure 3
SEM at D4P showing gland variability between samples from 
women during a natural cycle. (A) The glands are raised on 
circular hillocks with large, slit-like openings and demon-
strates an out-of-phase glandular appearance indicative of E2 
stimulation alone or insufficient P4 exposure. Scale bar = 0.1 
mm. (B) Epithelium of normal appearance displaying numer-
ous flattened glands with small, rounded openings. Scale bar 
= 0.1 mm.
0.1mm
0.1mm
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Group 4 – Downregulation plus HRT
A similar tissue response to treatment was observed in all
samples. The epithelium taken at Day 5P was representa-
tive of a mid-secretory phase epithelium. Mid to long
dense microvilli were observed on protruding cells, and
there was an abundance of well ciliated cells, secretory
droplets and fully developed uterodomes. The presence of
developing or fully developed uterodomes indicated a
progestogenic influence on the tissue (Figure 4b).
Group 5 – Menopause Control
Although the grading of the morphological characteristics
was variable between patients, trends were observed in the
samples examined.
Overall, epithelial tissue was difficult to find, with tissue
heterogeneity being pronounced. The heterogeneity was
observed as abutment between areas of different epithelial
architecture and an inconsistency in cell size and shape
(Figure 5a). Epithelial surface was usually flattened, with
cells often displaying raised cell borders; a few to moder-
ate number of glands with large openings were observed.
Cell separation, cell loss and apical membrane defects,
such as cell porosity, (Figure 5b) were a frequent occur-
rence. Denuded or bald cells were also frequently
observed.
Ciliated cells were only observed in 50% of the biopsies
examined, and when present, were short, sparse and dis-
played splayed tips. Singular cilia (Figure 5c) were also a
common feature of the tissue.
Microvillous cells were thinly populated with very low,
blebbed microvilli, with some of the samples examined
exhibiting the fusion of the low microvilli to form flat-
tened ridges (plicae).
No Uterodomes were observed in any of the samples.
Group 6 – Menopause plus HRT
Three of the samples examined showed a slight to no dif-
ference from pre-treatment biopsy.
Of the remaining samples, tissue was more uniform in
appearance than observed in the pre-treatment biopsies.
Epithelium was abundant and cellular heterogeneity was
less obvious. There was no change in gland number but
openings were round and generally small. No cell separa-
tion, cell loss or apical membrane defects were observed.
Apical cell protrusion was prevalent (Figure 6a) with only
some areas displaying a flattened epithelium. Ciliated
cells were moderately abundant with dense, long cilia. A
reduced incidence of single cilia was also observed.
Microvillous cells were uniformly small and polygonally
shaped, covered with dense microvilli that varied in
length.
Developing or fully developed uterodomes were observed
in a majority of the samples (Figure 6b). Secretory drop-
lets were moderately abundant.
SEM of tissue from a patient undergoing downregulation  (Group 3) Figure 4
SEM of tissue from a patient undergoing downregulation 
(Group 3). (A) The epithelial response to pituitary down-
regulation with GnRH is similar to that of an unstimulated 
epithelium. The microvillous cells are undemarcated and flat 
with sparsely distributed low or blebbed microvilli. Apical cell 
membrane is exposed (asterisk), apical defects (AP) and cell 
porosity (CP) apparent. Groups of cilia are still apparent but 
cilia number is reduced exposing bulging cellular apices 
(arrows). Scale bar = 5 µm. (B) The epithelial response in the 
same patient as (A) after pituitary down-regulation followed 
by HRT. A well stimulated, mature secretory phase morphol-
ogy suggestive of D5P was observed. Mid to long, dense 
microvilli were observed on protruding cells, and there was 
an abundance of well ciliated cells, secretory droplets and 
fully developed uterodomes (U). Scale bar = 5 µm.
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Groups 7 and 8 – Natural plus HST – Short follicular and Long 
Follicular phase
The results of morphological examination of the two
groups has been combined to reflect the changes that
occurred as a result of HST.
Overall both regimes, whether 7 or 14 days of E2 before
the commencement of P4, resulted in an improvement in
the appearance and amount of epithelium when com-
pared to Group 1, but little difference in uterdome devel-
opment between the cycles was observed. Of interest is the
finding that when uterodomes were observed to be fully
developed at Day 5P on a short E2 treatment cycle, they
were also found to be fully developed at Day 8P on a long
E2 treatment cycle. In patient samples that did not follow
this trend, fully developed uterodomes on Day 5P of a
short E2 treatment cycle, went on to exhibit clumping of
swollen microvillous tips (potentially a hyperoestrogenic
effect) on protruding cells on Day 8P of a long E2 treat-
ment cycle. This suggests that the longer E2 treatment
resulted in hyperoestrogenisation or in a shift of the nida-
tion window.
SEM of postmenopausal tissue Figure 5
SEM of postmenopausal tissue. (A) Tissue heterogeneity is 
pronounced with inconsistencies in cell size and shape. 
Arrows denote cell separation. Scale bar = 0.1 mm. (B) 
Microvillous cells are sparsely covered with very low or 
blebbed microvilli. Denuded or bald cells (asterisk) are fre-
quently seen. Scale bar = 10 µm. (C) Atrophic epithelium dis-
plays flat, pleiomorphic cells with obvious cell borders and 
single cilium (arrows). Scale bar = 10 µm.
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SEM of postmenopausal tissue after HRT Figure 6
SEM of postmenopausal tissue after HRT. (A) Microvillous 
cells are uniformly small and polygonally shaped, covered 
with dense microvilli and showing apical cell protrusion. Cili-
ated cells (c) are numerous. Scale bar = 10 µm. (B) Fully 
developed uterodomes (u) were observed in most patients 
at biopsy D6P. Scale bar = 10 µm.
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Of the four patients that were biopsied on Day 3P of the
short E2 treatment cycle, two displayed normally stimu-
lated endometria with pinopods and two exhibited
impoverished epithelia with sparse cell populations, cel-
lular erosion and cell disjunction.
Although the two hormonal regimes did not show differ-
ential changes in the morphology of the secretory epithe-
lium, there was an increase in pinopod abundance in
samples that had displayed few in the natural cycle prior
to HST. Where epithelium was well presented in the natu-
ral cycle, no further beneficial effect was observed with the
addition of HST.
Statistical analysis
Table 2 represents the significant difference between the
groups in the final analysis (P ≤ 0.05).
Preliminary analysis
Preliminary analysis of the morphological characteristics
provided a basis for the assumptions upon which the final
statistical analysis was based.
Groups 1 and 2 – Natural Cycle Control
Preliminary analysis indicated that the 2 groups signifi-
cantly differed in microvilli density and apical protrusion.
Group 1 had a median score of 2.5 and Group 2 a median
score of 1 for microvilli density, and 3 and 1 respectively
for apical protrusion (Table 3). Due to the innate mor-
phological inter-patient variability of the observed tissue,
it was decided that the groups would be combined into a
single natural cycle control group, Group 1 for the Final
analysis that follows.
Group 7 and Group 8 – short and long follicular phase
Preliminary analysis indicated that Group 7 significantly
differed from group 8 in terms of cell heterogeneity only.
Group 7 had a median score of 2 and Group 8 a median
score of 3 (data not shown). In considering the response
of all characteristics it was decided to redefine the two
groups by biopsy Day P rather than retain grouping
according to the length of E2 prior to P4 commencement.
Data was regrouped in terms of biopsy Day 5P (Group 7)
and Day 8P (Group 8). Tissue from biopsy Day 3P was not
included in the analysis. On reanalysis, using the Day P as
a grouping factor, the groups were found to significantly
differ in secretion only (Table 2) with Group 7 having a
Table 2: Statistical Analysis of morphological characteristics between Groups showing significant differences and median scores.
Epithe-
lial 
abund-
ance
Tissue 
inhomo-
geneity
Cell 
inhomo-
geneity
Gland 
abund-
ance
Gland 
opening
Cilia 
groups
Single 
cilium
Micro-
villi 
height
Micro-
villi 
density
Apical 
mem-
brane 
defects
Cell sep-
aration
Denu-
ded 
apices
Flat-
tened 
cells
Deflated 
cells
Apical 
protru-
sion
Utero-
dome – 
shape
Utero-
dome – 
abund-
ance
Cell 
borders
Secre-
tion
Plicae
group 1 vs 
group 4
SD 
(2.5,3)
SD 
(2.5,1)
SD (2,3) SD 
(2.5,3)
SD (0,0) SD (2,3) SD (0,1) SD 
(2.5,2)
group 1 vs 
group 5
SD 
(2.5,1)
SD 
(2,0.5)
SD 
(0,0.5)
SD (2,1) SD (2,1) SD (0,1) SD 
(0,0.5)
SD (0,2) SD (0,2) SD (0,1) SD (2,0) SD (1,0) SD (1,0) SD (1,2) SD (2,0) SD 
(0,0.5)
group 1 vs 
group 6
SD 
(0,0.5)
SD (0,1) SD (0,0) SD (1,3)
group 1 vs 
group 7
SD (2,1) SD (2,1)
group 1 vs 
group 8
SD (0,0) SD (0,0) SD (2,1)
group 3 vs 
group 5
SD (3,1) SD 
(2,0.5)
group 4 vs 
group 5
SD (3,1) SD 
(1,2.5)
SD 
(2,1.5)
SD (1,3) SD 
(3,0.5)
SD 
(0,0.5)
SD (2,1) SD (3,1) SD (0,1) SD 
(0,0.5)
SD (0,2) SD (0,2) SD (0,1) SD (3,0) SD (1,0) SD (2,0) SD (0,2) SD 
(2.5,0)
SD 
(0,0.5)
group 4 vs 
group 6
SD (3,3) SD (3,2) SD 
(0,0.5)
SD (3,2) SD (0,1) SD (3,2) SD (2,2)
group 4 vs 
group 7
SD (1,2) SD (2,1) SD (3,2) SD (0,0) SD (3,1) SD (0,1) SD 
(2.5,2)
SD 
(0.5,0)
group 4 vs 
group 8
SD (1,3) SD (3,2) SD (2,1) SD (3,1) SD (0,0) SD (3,1) SD (2,1) SD (0,1) SD 
(2.5,1)
group 5 vs 
group 6
SD (1,3) SD 
(2.5,2)
SD 
(3,1.5)
SD 
(0.5,2)
SD (1,2) SD (1,2) SD (1,2) SD 
(0.5,0)
SD (2,1) SD (2,1) SD (1,0) SD (0,2) SD (0,3) SD (0,2) SD (2,0) SD (0,2)
group 5 vs 
group 7
SD (1,3) SD (1,2) SD 
(3,1.5)
SD 
(0.5,0)
SD 
(0.5,0)
SD 
(0.5,0)
SD 
(0.5,0)
SD (2,0) SD (2,0) SD (1,0) SD (0,1) SD (0,1) SD (0,1) SD (2,1) SD (0,2)
group 5 vs 
group 8
SD (1,3) SD 
(1.5,3)
SD (1,2) SD (3,2) SD 
(0.5,0)
SD (1,3) SD 
(0.5,0)
SD 
(0.5,0)
SD (2,0) SD (2,0) SD (1,0) SD (0,1) SD (0,1) SD (0,1) SD (2,1) SD (0,1)
group 6 vs 
group 7
SD 
(0.5,0)
SD (2,1) SD (2,2) SD (0,0) SD (1,0) SD (0,0) SD (2,1)
group 6 vs 
group 8
SD 
(1.5,3)
SD 
(0.5,0)
SD (2,1) SD (0,0) SD (1,0) SD (0,0) SD (2,1)
group 7 vs 
group 8
SD (2,1)
SD = significant difference at P ≤ 0.05 Median score of groups is shown in brackets (group a, group b) Key to the Groups used in the Analysis Group 
1 Control – natural cycle (Combined) Group 3 Downregulation Group 4 Downregulation plus HRT Group 5 Menopause Control Group 6 
Menopause plus HRT Group 7 Natural plus HST – Day 5P Group 8 Natural plus HST – Day 8PReproductive Biology and Endocrinology 2004, 2 http://www.rbej.com/content/2/1/21
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median score of 2 and Group 8 a median score of 1 (Table
3)
Group 3 – Downregulation vs Group 5 – Menopausal Control
Due to the small sample size, results for this group were
included for interest only. Of note was the similarity of
tissue from these 2 patients to that of tissue obtained from
menopausal patients. The groups differed significantly
only in terms of epithelial abundance and cilia groups
(Table 2), with a median score of 3 (Group3) and 1
(Group 5) for epithelial abundance, and 2 (Group 3) and
0.5 (Group 5) for cilia groups (Table 3).
Final Analysis
Natural versus Hormone replacement
Natural Control Combined (Group 1), Downregulation
plus HRT (Group 4), Menopause plus HRT (Group 6)
Natural plus HST D5P (Group 7) and Natural plus HST
D8P (Group 8)
Group 1 vs Group 4: From Table 2, analysis indicated that
Group 1 and Group 4 differed significantly in 8 of the
morphological characteristics observed. These differences
in the characteristics suggest a retardation of the uterine
phase in Downregulation plus HRT when compared to
tissue from patients on a natural cycle.
Group 1 vs Group 6: Although responding to hormonal
priming, menopausal tissue (Group 6) differed signifi-
cantly from Group 1 tissue in the presence of single cil-
ium, flattened cells, deflated cells and uterodome shape.
The results indicate that menopausal tissue was advanced
in terms of uterdome shape, suggestive of an epithelium
that had passed the prime nidation window.
Group 1 vs Group 7 and Group 8: There was little significant
difference between the Groups (Table 2). Group 7 differed
from Group 1 in terms of microvilli height and apical pro-
trusion. Group 8 significantly differed from Group 1 in
denuded apices and flattened cells, with a greater score
range being seen in Group 1 (Table 3), and in the amount
of secretion.
Downregulation plus HRT vs Natural plus HST
Downregulation plus HRT (Group 4), Natural plus HST
D5P (Group 7) and Natural plus HST D8P (Group 8)
Group 4 vs Group 7 and Group 8: These groups were signif-
icantly different in 7 of the same characteristics (Table 2).
Group 4 additionally differed significantly to Group 7 in
the presence of plicae. Group 4 differed significantly to
Group 8 in another 2 characteristics, cilia groups and uter-
odome abundance. The trend suggests that downregula-
Table 3: Group median values and score range for the morphological characteristics used in the final analysis.
Epithe-
lial 
abund-
ance
Tissue 
hetero-
geneity
Cell 
hetero-
geneity
Gland 
abunda-
nce
Gland 
opening
Cilia 
groups
Single 
cilium
Micro-
villi 
height
Micro-
villi 
density
Apical 
mem-
brane 
defects
Cell 
separa-
tion
Denude
d apices
Flat-
tened 
cells
Deflated 
cells
Apical 
protrusi
on
Utero-
dome – 
shape
Utero-
dome – 
abundan
ce
Cell 
borders
Secre-
tion
Plicae
G r o u p  1 M e d i a n 322222 0 22 000002111 2 0
C o m b i n e d M i n i m u m 111000 0 11 000000000 0 0
n  =  2 5 M a x i m u m 333333 0 33 111213332 3 2
(Group 1) Median 2.5 2.5 2 2 2 2 0 2 2.5 0 0 0 0 0 3 1 1.5 0 2 0
n  =  1 0 M i n i m u m 111111 0 11 000001000 1 0
M a x i m u m 333233 0 33 111213332 3 1
( G r o u p  2 ) M e d i a n 312112 0 11 000001111 2 0
n  =  1 5 M i n i m u m 111000 0 11 000000000 0 0
M a x i m u m 333333 0 33 111103331 3 2
G r o u p  3 M e d i a n 323122 0 11 203301003 0 2
n  =  2 M i n i m u m 323122 0 11 203301003 0 2
M a x i m u m 323122 0 11 203301003 0 2
G r o u p  4 M e d i a n 311213 0 23 000003120 2 . 5 0
n  =  1 0 M i n i m u m 310112 0 22 000003000 2 0
M a x i m u m 322223 0 33 001113330 3 0
G r o u p  5 M e d i a n 1 2 . 5 1 . 5 13 0 . 5 0 . 5 11 1 0 . 5 2210002 0 0 . 5
n  =  1 8 M i n i m u m 111000 0 11 000100000 0 0
M a x i m u m 333232 2 23 213321003 1 2
G r o u p  6 M e d i a n 32 1 . 5 2 1 . 5 2 0 . 5 22 000102320 2 0
n  =  1 8 M i n i m u m 211001 0 11 000000000 0 0
M a x i m u m 333323 1 33 112213332 3 2
G r o u p  7 M e d i a n 322212 0 12 000001111 2 0
n  =  1 8 M i n i m u m 111110 0 11 000000000 0 0
M a x i m u m 333333 0 23 111102231 3 2
G r o u p  8 M e d i a n 313222 0 11 000001111 1 0
n  =  1 3 M i n i m u m 111000 0 01 000000000 0 0
M a x i m u m 333333 0 33 000003331 2 2
Group 1 Combined Control – natural cycle (Combined groups 1 and 2) Group 3 Downregulation Group 4 Downregulation plus HRT Group 5 
Menopause Control Group 6 Menopause plus HRT Group 7 Natural plus HST – Day 5P Group 8 Natural plus HST – Day 8P Key: Groups in () 
indicate values prior to combination for final analysisReproductive Biology and Endocrinology 2004, 2 http://www.rbej.com/content/2/1/21
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tion prior to HRT results in greater tissue stimulation, in
terms of morphological characteristic development, as
observed by a consistently higher median score for Group
4 in the characteristics that were significantly different.
Menopausal Control vs Natural Cycle, HRT and HST
Menopausal (Group 5), Natural (Group 1), Downregula-
tion plus HRT (Group 4), Menopause plus HRT (Group 6),
Natural plus HST D5P (Group 7) and Natural plus HST
D8P (Group 8)
As expected of hormone depleted tissues, Group 5 dif-
fered significantly to all other hormone exposed groups in
a majority of the morphological characteristics observed
(Table 2).
Menopause plus HRT versus Downregulation plus HRT and Natural 
plus HST
Menopause plus HRT (group 6), Downregulation plus HRT
(Group 4),) Natural plus HST D5P (Group 7) and Natural
plus HST D8P (Group 8)
Group 4 vs Group 6: Surprisingly these groups differed sig-
nificantly in a number of the morphological features
observed (Table 2). The presence of single cilium indi-
cated that evidence of senescence remained in the meno-
pausal tissue even after HRT. Overall, the tissue that had
been downregulated prior to HRT demonstrated an
enhanced response to HRT in comparison to menopausal
tissue (Tables 2 and 3).
Group 6 vs Group 7 and Group 8: Both natural HST treat-
ment groups differed significantly from the menopause
plus HRT group in the presence of single cilium, microvilli
density, denuded apices, flattened cells and deflated cells
(Table 2). Group 8 displayed more cell heterogeneity but
less secretion than Group 6 (Tables 2 and 3). Group 7 dif-
fered significantly from Group 6 in having a lower median
score in microvilli height and apical protrusion (Table 2).
Results indicate that tissue from a natural cycle has a
retarded response to HST in comparison to menopausal
tissue response to HRT.
Summary
Overall, when considering all natural cycle and HRT or
HST manipulated cycles, secretion was consistently signif-
icantly different between Groups 1, 4, 6 and Group 8, with
Group 8 having a lower median score.
Discussion
The variable morphological response of the endometrium
to endogenous hormones in the naturally cycling patients
reflects either an unique physiological response to hor-
mones at the target tissue, or an insufficiency in the
amount of endogenous hormones at the level of the uter-
ine epithelium, or both. Problems associated with the
endogenous hormone response, coupled with the varia-
bility observed in the response of women with no ovarian
function to exogenous E2 and P4, [5,51,6,52,53] high-
lights the need to optimize both the dose and timing of
hormone replacement regimes and where possible, to tai-
lor regimes to suit individual patients [17].
Tissue samples examined from the naturally cycling
patients consistently displayed epithelial tissue, a hetero-
geneity of cellular morphology and a variable morpholog-
ical response to endogenous hormones. Having previous
failed ET attempts, observations of endometrial variability
in these patients indicates the importance of attaining a
mature 'in-phase' endometrium if implantation is to
proceed.
In general, uterodomes appear after D5 of P4 stimulation
[35] and the fact that several patients displayed develop-
ing uterodomes prior to this time (D3P) indicated that
they would have been fully developed by D5P. However,
the presence of fully developed uterodomes on D3P
would have placed these patients into the 'patient varia-
bility' group where an out-of-phase epithelium can occur
with a temporal span of up to 5 days [39].
The presence of large exposed glands in some of the
patients suggested an epithelium under the influence of E2
alone or insufficiently stimulated by P4, thus out-of-phase
and indicative of late proliferative endometrium. Other
indicators included areas of tissue displaying large, pleio-
morphic cells with raised cell borders.
The observation of patients, within the naturally cycling
control group, with a hyperplastic (over proliferative/
hyperoestrogenic) [46,47] endometrium demonstrated
the often unsuspected endometrial variability in naturally
cycling women, adding weight to the argument in support
of uterine biopsy and SEM for direct visualisation of
endometrial morphology.
Patients recruited into the downregulation cohort dis-
played a more uniform tissue response to the HRT that
followed. The two patients that had biopsies taken after
pituitary down-regulation but prior to HRT, indicated that
an unstimulated, flat epithelium, resembling the unstim-
ulated epithelium of the postmenopausal uterus, can be
seen in ovulating women, and that HRT in a consecutive
cycle can restore that epithelium to a mature functional
state. It was interesting to note however, that statistical
analysis of the morphological characteristics indicated
that HRT after downregulation was significantly different
from the natural cycle in a number of characteristics. The
median score of downregulation plus HRT showed thatReproductive Biology and Endocrinology 2004, 2 http://www.rbej.com/content/2/1/21
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exogenous hormones had a greater tissue effect than that
found with exposure to endogenous hormones.
The D5P biopsy taken from these downregulated patients
following hormone stimulation, displayed developing
and fully developed uterodomes. As uterodomes are
known to occur after 5–7 days of P4 (in a natural cycle)
[55,43] this appearance of uterodomes indicates that the
HRT regime given was sufficient to stimulate a previously
downregulated, flattened uterine epithelium. All patients
had a similar morphological response, with a well stimu-
lated epithelium representative of the mid secretory
phase. The presence of developing uterodomes was sug-
gestive of a receptive (or pre receptive) state, which under a
progestegenic influence, is indicative of the maturing epi-
thelium required for successful blastocyst implantation.
Patients that displayed developing uterodomes at D5P
could have gone on to develop them later in the cycle, or
may have benefited from HRT dose manipulation.
The variability of tissue observed from menopausal
patients can be explained by the climacteric process. Dur-
ing the climacteric period there is a physiological decline
in ovarian function, a consequential fall in the secretion
of both E2 and P4, and an endometrium that eventually
becomes atrophic. Since that atrophic state represents the
preserved or 'petrified' cycle that existed when the meno-
pause started, it may have several forms. If the last men-
strual cycle was ovulatory and ended with a regular
menstrual flow, then a 'simple' atrophy will develop.
However, if the last cycle or cycles were anovulatory, or if
the proliferative phases were irregular, then the 'petrified'
state of the last proliferative phase will be observed [56].
A dramatic improvement from the menopausal baseline
of the 20 epithelial characteristics chosen for the study
was observed after 2 cycles of HRT. The baseline biopsies
showed only scant areas of an unstimulated epithelium
covering the stroma [57]. After HRT, there was an
abundance of epithelium which was observed to be simi-
lar to that of the mid secretory stage, D19-22, of a func-
tionally receptive epithelium [47]. The microvillous cells
were small and uniformly polygonal in shape, had apical
cell protrusion and were covered with dense, medium to
long microvilli. There was no evidence of cell defect or
separation as found in the baseline biopsy. Ciliated cells
were moderate to abundant and cilia were tall, upright
and covering the entire cell surface [58]. Uterodomes were
found fully developed in 10 patients, developing in 3 and
absent in 5.
Of the 5 patients with no uterodomes, 3 patients showed
little morphological response to HRT indicating that the
hormone dose was insufficient to stimulate the
epithelium, rather than an inability of the epithelium to
respond.
Since patient variability is known to occur with a temporal
5 day 'out-of-phase' period [55], it is probable that the
24–48 hour window for their appearance either preceded
the biopsy date (where biopsy date was D23) or was yet to
occur. Since there is no information as to how many cycles
of HRT are required before a maximum epithelial
response is achieved, it is possible, from the findings of
this study, that severely atrophic endometria may need
more than 2 months HRT before achieving a standard epi-
thelial response [59].
Statistical analysis showed that tissue from menopausal
patients after HRT differed significantly from natural cycle
control patients in 4 of the characteristics observed. How-
ever, menopause after HRT differed significantly from
downregulation after HRT in 7 of the characteristics
observed. When considered with regard to the median
scores, the tissue response to HRT after downregulation
seems more advanced, with menopausal tissue retaining
some of its pre-stimulation characteristics, such as single
cilium, less dense microvilli and flattened cells.
Manipulation of the follicular phase in naturally cycling
patients did not interfere with the morphological integrity
of the secretory epithelium as observed by SEM. Our
results also demonstrated that uterodome appearance,
abundance and shape did not appear to be compromised
by utilizing a short follicular phase cycle.
Seven pregnancies which resulted from this part of the
study were achieved using the long follicular phase regime
with 5 days of P4 in patients who were assessed by previ-
ous biopsy to have optimal epithelium with this regime
[13]. Perhaps premature P4, after a short cycle of E2, may
accelerate the closure of the nidation window and com-
promise the chances of successful implantation [41,42].
This is also indicated by a significant difference in secre-
tion, with tissue from the long follicular cycle being less
secretory than that from the short follicular cycle (Table
2).
The function of uterodomes in humans is still unknown
but their appearance at, or just prior to the time of implan-
tation suggests they are necessary for the functionality of
the secretory epithelium if implantation and pregnancy
are to progress. While pregnancies were achieved with ET
on D19 (D5P) of a long follicular phase cycle, fully devel-
oped uterdomes were observed on both D10 (D3P) and
D12 (D5P) of the short follicular phase cycle. This finding
again highlights the potential benefit of repeat biopsies to
fine tune individual hormonal priming and the role that
P4 plays in determining endometrial receptivity.Reproductive Biology and Endocrinology 2004, 2 http://www.rbej.com/content/2/1/21
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In artificial cycles maintained with exogenous hormones,
uterodomes have been shown to occur around D22 (D8
P) [34], suggesting that the window of receptivity in artifi-
cial cycles, induced by HRT, can be postponed [34,36,39].
Studies where sequential sampling was performed during
the same cycle of natural or artificial cycles (non ovarian
stimulated), the timing of uterdome appearance was
found to vary up to 5 days between women [55]. This
individual variability could explain our observation of
fully developed uterdomes on both days 3 and 5 of P4 in
the same patient, although not in the same cycle. How-
ever, we did not observe an abundance of uterdomes on
day 22 (D8P) [55]. In contrast, previous work has shown
that uterodome appearance is dependant on P4 in a study
on naturally cycling women where exogenous E2 was not
supplemented [13].
Exogenous hormone adjusted cycles may require several
treatment cycles before synchronisation of morphological
events occurs in patients having functional ovaries. There
is also the possibility of a cumulative affect from both
sources of hormones. All naturally cycling patients that
took part in the HST study displayed uterdomes in one or
more of the 3 cycles examined (natural cycle, short
follicular phase, or long follicular phase). Where the
patient had an understimulated epithelium in the natural
control cycle, exogenous hormones in subsequent cycles
restored the morphological characteristics of the
endometrium but did not necessarily result in the forma-
tion of uterodomes. Where the morphology of the secre-
tory epithelia appeared normal in the natural cycle no
further enhancement was noted during the following HST
cycles, supporting the findings of Martel et al., [47] and
Nikas et al., [39]. However, a subsequent cycle of HST did
not always preserve the integrity of a secretory epithelium
when observed in the natural control cycle. This supports
the notion of a possible 'threshold' effect where the
number of hormonal treatment cycles prior to ET may
impinge on morphological integrity and impact on
implantation outcome.
In summary, the only significant difference observed
between the length of the follicular cycle ie: between 7 or
14 days of E2 therapy was the level of secretion. Where
uterodomes were observed on D3 or D5 of P4 exposure
they were absent by D8P suggesting that their appearance
at or just prior to the time of implantation is necessary for
the functional integrity of the endometrium if pregnancy
is to progress. Baseline biopsies and manipulation of the
secretory epithelium until uterodomes are observed is
thus a useful tool for timing ET transfer.
Conclusions
The findings of this study suggest that pituitary down reg-
ulation of IVF patients with GnRH agonists prior to HRT
may assist in standardising epithelial surface appearance
when compared to the variability observed during a natu-
ral control cycle. However, the tissue response is signifi-
cantly different from the response observed in natural or
menopausal tissue after HST or HRT. HRT on a post-men-
opausal endometrium or down-regulation followed by a
controlled hormonal regime in IVF patients may serve to
optimise endometrial priming in preparation for embryo
transfer but close observation of morphological character-
istics is required to maximize the potential outcome of
these hormone treatment regimes. HST in a natural cycle
has little significant effect on the morphological character-
istics of a well stimulated epithelium but may be benefi-
cial in timing the appearance of uterodomes. It also
demonstrates that manipulation of the follicular phase is
possible, that the appearance of uterodomes is dependent
on P4 exposure, and that maintaining the follicular phase
length (14 days) may have beneficial effects on pregnancy
outcomes by normalizing an otherwise variable tissue
response.
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